Visseren, Frank L.J.
University Medical Center Utrecht
30 papers on CoChatORCID 0000-0003-3951-5223
Most cited papers
- Verified
Random measurement error: Why worry? An example of cardiovascular risk factors
Brakenhoff, T. B., van Smeden, M., Visseren, F. L. J., & Groenwold, R. H. H. (2018) · PLOS ONE
Statistical Methods in EpidemiologyAdvanced Causal Inference Techniques
Cited by 52
- Verified
Differential effects of renin–angiotensin–aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial
Dorresteijn, J. A. N., Schrover, I. M., Visseren, F. L. J., Scheffer, P. G., Oey, P. L., Danser, A. H. (., & Spiering, W. (2013) · Journal of Hypertension
Renin-Angiotensin System StudiesBlood Pressure and Hypertension Studies
Cited by 50
- Verified
A pilot-study to identify the feasibility of an Internet-based coaching programme for changing the vascular risk profile of high-risk patients
Goessens, B. M. B., Visseren, F. L. J., de Nooijer, J., van den Borne, H. W., Algra, A., Wierdsma, J., & van der Graaf, Y. (2008) · Patient Education and Counseling
Mobile Health and mHealth ApplicationsTelemedicine and Telehealth Implementation
Cited by 40
- Verified
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene
Heidemann, B. E., Koopal, C., Baass, A., Defesche, J. C., Zuurbier, L., Mulder, M. T., Roeters van Lennep, J. E., Riksen, N. P., Boot, C., Marais, A. D., et al. (2022) · Clinical Genetics
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 27
- Verified
Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts
Heidemann, B. E., Wolters, F. J., Kavousi, M., Gruppen, E. G., Dullaart, R. P., Marais, A. D., Visseren, F. L., & Koopal, C. (2021) · Atherosclerosis
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 21
- Verified
Expanding the triglyceride range in clinical trials: therapeutic opportunities
Nordestgaard, A. T., Pradhan, A. D., Everett, B. M., MacFadyen, J. G., Bhatt, D. L., Visseren, F. L. J., Libby, P., Santos, R. D., Nissen, S. E., Nordestgaard, B. G., et al. (2025) · European Heart Journal
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free